The Human Upgrade: Biohacking for Longevity & Performance

Why Women’s Joints Are Failing 10x Faster : 1349

72 snips
Oct 21, 2025
Kiran Krishnan, a seasoned research microbiologist and Chief Scientific Officer at Calroy Health Sciences, shares his insights on the critical factors behind joint health decline. He reveals how systemic inflammation and mitochondrial dysfunction contribute to cartilage loss, highlighting that joint pain is often mishandled by conventional treatments. Krishnan discusses innovative solutions, including Cartigenix HP, which utilizes unique boswellia actives and celery seed extracts to combat inflammation. Furthermore, he emphasizes the importance of hormonal changes in midlife women, advocating for proactive measures to maintain joint health.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ADVICE

Avoid Long-Term Painkiller Reliance

  • Do not rely on opioids or common painkillers as primary long-term joint therapy.
  • Focus on root-cause anti-inflammatory and regenerative treatments instead of masking pain.
ADVICE

Short-Term Tests, Long-Term Commitment

  • Expect measurable changes in inflammation and cartilage markers within seven days.
  • Continue treatment for weeks to shift degeneration markers and improve pain and function by 90 days.
INSIGHT

Boswellia Beyond AKBA

  • Specific boswellia molecules (serotol, terakelic acid) can both induce repair and reduce IL-6/TNF-alpha.
  • Targeted phytochemistry outperforms generic extracts by modulating repair and key cytokines.
Get the Snipd Podcast app to discover more snips from this episode
Get the app